The Lancet: New oral drug regimens cure hardest-to-treat hepatitis C

(The Lancet) Two new pill-only antiviral drug regimens could provide shorter, more effective treatment options with fewer side effects for the majority of patients infected with hepatitis C, even those most difficult to treat, according to the results of two studies published in The Lancet.